Section of a breast tumor-derived organoid, stained with antibodies recognizing CK8/18 (in red); CK14 (in green); E-cadherin (in purple) and DAPI (nuclei, in blue).
I obtained my PhD in Biochemistry in 2011. During my training, I have worked both in national and foreign institutions, such as MRC Protein Phosphorylation Unit (UK) and Harvard Medical School (US). In the last years I have published 37 papers with more than 5600 citations so far. I have participated in 20 International Conferences and obtained several competitive grants, from FEBS, US Fulbright International Program, MINECO, Community of Madrid, AECC, La Caixa… among others.
From 2015, as senior postdoc, I have led at CNIO the development of a new technology, aimed to improve the differentiation capacity of stem cells. I recently published the initial part of this project in The EMBO Journal (as first and co-corresponding author) and submitted a patent application, now in national phases. Recently in 2019, I was awarded- as Project Leader- by two prestigious Innovation Programs from Spain and US (Caixa Impulse and MIT IDEA2 Global) to develop our technology one step forward.
Now, from August 2020, I have started my own research group as Junior PI at Complutense University (Madrid), together with my PhD student Nuria García. We are focused on the development of novel Advanced Therapies and funded by the AECC Scientific Foundation and La Caixa Foundation.
María Salazar Roa, PhD